Finance ForgeBETA
Crear cuenta gratis
1)Empresas2)Rankings3)Iniciar sesión
Finance Forge Terminal v1.51.3
PrivacidadTérminosCookiesAviso Legal
● Connected
CI US Equity
Cigna Group
282.53USD▼ 0.29%
Healthcare
Healthcare Plans
96)Comparar97)Tesis →
Market Cap
$74.7B
Shares Outstanding
264M
P/E (TTM)
11.6×
EV/EBITDA
8.2×
Revenue (TTM)
$282.4B
Net Income (TTM)
$6.4B
— Annual —FY2025
Revenue
$274.9B
Gross Margin
21.8%
Operating Margin
3.4%
Net Margin
2.2%
ROE
14.3%
ROCE
9.1%
Net Debt/EBITDA
1.9×
Current Ratio
0.85
D/E Ratio
0.74
Dividend Yield
2.2%
Book Value / Share
157.86
CI US Equity
282.53USD▼ 0.29%
Tesis →

Cigna Group (CI): análisis fundamental y valoración

Cigna Group cotiza a 282.53 USD y tiene una capitalización bursátil de $74.7B. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud

Price History
Loading...
Perfil
BolsaNYSEPaísUnited StatesEmpleados65,669Beta0.30Web↗ www.thecignagroup.com

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering…

Múltiplos de Valoración
P/E (Annual)
12.5×
P/E (TTM)
11.6×
P/FCF (Annual)
—
P/FCF (TTM)
—
EV/EBITDA
8.2×
EV/Revenue
0.4×
P/Sales
0.3×
P/Book
1.8×
Rentabilidad (Último Anual)
Gross Margin
21.8%
Operating Margin
3.4%
Net Margin
2.2%
FCF Margin
—
ROE
14.3%
ROCE
9.1%
ROA
3.8%
Effective Tax Rate
23.4%
Métricas TTM
Revenue TTM
$282.4B
Gross Profit TTM
$58.3B
Operating Income TTM
$10.0B
Net Income TTM
$6.4B
FCF TTM
—
EPS TTM
24.17
Quarters Used
4
TTM Period
2025-09-30 → 2026-06-30
Solidez del Balance
Net Debt
$23.2B
Net Debt / EBITDA
1.9×
Debt / Equity
0.74
Current Ratio
0.85
Interest Coverage
6.6×
Working Capital
−$8.5B
Book Value / Share
157.86
Net Debt / Share
87.78
Crecimiento (YoY)
Revenue YoY
+11.2%
Net Income YoY
+73.5%
FCF YoY
—
EPS Diluted YoY
+83.0%
Retorno al Accionista
Dividend Yield
2.2%
Payout Ratio
27.0%
FCF / Share
—
CapEx % Revenue
—
Rev / Employee
4M
Próximos Eventos
Ex-Dividendo
2026-09-08
Pago Dividendo
2026-09-23
Historial EPS
Periodo2026-112026-072026-042026-02
Real—$7.78$7.79$8.08
Estimado$7.51$7.60$7.61$7.88
Sorpresa—+2.4%+2.4%+2.5%
Empresas similares
Smart Money
vs Sector: Healthcare (1130 empresas)
MétricaCIMediana SectorΔ
Gross Margin21.8%57.0%-35.3%
Operating Margin3.4%-38.6%+42.0%
Net Margin2.2%-33.6%+35.7%
FCF Margin—-13.9%—
ROE14.3%-40.4%+54.7%
ROA3.8%-32.0%+35.8%
Current Ratio0.852.84-1.99
Debt / Equity0.740.28+0.46
Scoring Fundamental
Piotroski F-Score
7/ 9Moderado
✓F1ROA positivo (rentabilidad activos)
✓F2Flujo caja operativo positivo
✓F3ROA mejora vs año anterior
✓F4Calidad de beneficios (OCF > ROA)
✗F5Apalancamiento baja
✓F6Liquidez mejora (current ratio)
✓F7Sin dilución accionarial
✗F8Margen bruto mejora
✓F9Rotación activos mejora
Altman Z-ScoreZona Gris
2.68
x1_working_capital-0.054
x2_retained_earnings0.303
x3_ebit0.058
x4_market_equity0.643
x5_sales1.741
>2.99 segura · 1.81–2.99 gris · <1.81 riesgo
Capital Allocation
4/ 8Moderada
✗FCF+Free cash flow positivo
✗FCFmMargen FCF > 10%
✓DilucSin dilución significativa (< 2%/año en 3 años)
✓Rev↑Revenue CAGR 3 años > 5%
✗ROCERetorno sobre capital empleado > 10%
✓DeudaDeuda neta/EBITDA < 3× (o posición de caja neta)
✓Mg↑Margen operativo ≥ hace 2-3 años (tolerancia -2pp)
✗Inv.R&D + Capex > 3% de revenue (reinversión en el negocio)
Histórico Piotroski F-Score
Histórico de Múltiplos